Cholangiocarcinoma: new perspectives for new horizons-Reference-Cited by-同舟云学术

Cholangiocarcinoma: new perspectives for new horizons

Published:2021-11-09 Issue:12 Volume:15 Page:1367-1383
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Rimini Margherita¹,Puzzoni Marco²,Pedica Federica³,Silvestris Nicola⁴⁵,Fornaro Lorenzo⁶,Aprile Giuseppe⁷,Loi Eleonora⁸,Brunetti Oronzo⁴,Vivaldi Caterina⁶,Simionato Francesca⁷,Zavattari Patrizia⁸,Scartozzi Mario²,Burgio Valentina⁹,Ratti Francesca¹⁰,Aldrighetti Luca¹⁰,Cascinu Stefano⁹,Casadei-Gardini Andrea⁹

Affiliation:

1. Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy

2. Medical Oncology, University and University Hospital of Cagliari, Italy

3. Department of Pathology, San Raffaele Scientific Institute, Milan, Italy

4. Department of oncology, Instituto Di Ricovero E Cura a Carattere Scientifico (IRCCS) Istituto Tumori “Giovanni Paolo Ii” of Bari, Bari, Italy

5. Department of Biomedical Sciences and Human Oncology, Aldo Moro University of Bari, Bari, Italy

6. Department of medical oncology, U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy

7. Department of Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, Vicenza, Italy

8. Department of Biomedical Sciences, Unit of Biology and Genetics, University of Cagliari, Cagliari, Italy

9. Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy

10. Hepatobiliary Surgery Division, IRCCS San Raffaele and Vita-Salute University, Italy

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2021.1991313

Reference171 articles.

1. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

2. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

3. Cholangiocarcinoma risk factors and the potential role of aspirin

4. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population;European Journal of Cancer;2024-09

2. Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer;Current Treatment Options in Oncology;2024-07-27

3. Integrating Molecular Insights into Biliary Tract Cancer Management: A Review of Personalized Therapeutic Strategies;Current Oncology;2024-06-21

4. Photodynamic therapy inhibits cancer progression and induces ferroptosis and apoptosis by targeting P53/GPX4/SLC7A11 signaling pathways in cholangiocarcinoma;Photodiagnosis and Photodynamic Therapy;2024-06

5. Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study;Targeted Oncology;2024-05